Game-Set-MATCH: Liquid Biopsy Advances to the Next Round.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40779159.
- Also identified by DOI 10.1158/1078-0432.CCR-25-1927.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A recent article evaluated the concordance rate between tumor and plasma genotyping for detecting actionable genomic alterations to guide targeted therapy. These results support the utility of liquid biopsy for enrolling patients into genomically guided trials, especially in scenarios in which tissue is unavailable or biopsy is not feasible. See related article by Gouda et al., p. 4299.
Medical subject headings
- Neoplasms
- Biomarkers, Tumor